Contact Us Register for Updates Print

Register for Updates

Stay current on Valeritas.

Sign up today

Clinical Investigator

Interested in participating in a Valeritas clinical study?

Sign up today

Delivery of the V-Go®

Simple basal-bolus,

Disposable
Insulin Delivery
Device

The V-Go developed by Valeritas Drug Delivery Systems
  • Users fill the V-Go® with their prescribed insulin using an included disposable filling accessory called the EZ Fill.
  • The V-Go® is then applied to the skin in a discreet location like the abdomen or back of the arm.
  • By following the patient instruction guide, patients can then start the flow of insulin (preset basal rate of insulin) and self-administer their bolus doses at mealtimes.
The V-Go®
The V-Go® Product Overview

Engineered to Simplify Basal-Bolus Insulin Delivery

Has only 4 buttons:
Needle Button the V-Go's needle button must be pressed to start basal rate of insulin Press once to start
basal rate of insulin
The V-Go's bolus ready button prepares the insulin for on-demand insulin dosing Bolus Ready Button 2 buttons for on-demand bolus dosing at meals
(1 push = 2 Units)
The V-Go's blolus delivery button is for on-demand dosing at meals. 1 push is equal to two units of insulin Bolus Delivery Button
The V-Go's needle release button can be slid and pressed once to stop the flow of insulin after 24 hours for adults suffering from type 2 diabetes Needle Release Button Slide and press once to stop
flow of insulin after 24 hours

The V-Go Instructions for Patient Use. Valeritas, Inc., 2011.

The V-Go® is a simple, fully disposable device for the delivery of basal-bolus insulin therapy in adults with Type 2 diabetes. The V-Go® provides a continuous preset basal rate of insulin and allows for on-demand bolus dosing around mealtimes, thereby providing an alternative to taking multiple daily insulin injections.

The V-Go® is small, lightweight and worn under the patients clothing. It measures just 2.4 x 1.3 x 0.5 inches and weighs approximately 1 ounce when filled with insulin. Patients apply a new V-Go® to the skin daily for one 24-hour period. The V-Go® is not electronic, making it easy to operate and use.

Important Risk Information:

If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Disposable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with the V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with the V-Go use include skin irritation from the adhesive pad or infections at the infusion site. The V-Go should be removed before any magnetic resonance imaging (MRI) testing.